NL7108858A - - Google Patents
Info
- Publication number
- NL7108858A NL7108858A NL7108858A NL7108858A NL7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A NL 7108858 A NL7108858 A NL 7108858A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5750770 | 1970-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7108858A true NL7108858A (fr) | 1972-01-03 |
Family
ID=13057634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7108858A NL7108858A (fr) | 1970-06-30 | 1971-06-25 |
Country Status (8)
Country | Link |
---|---|
US (1) | US3796700A (fr) |
BE (1) | BE768925A (fr) |
CA (1) | CA954856A (fr) |
DE (1) | DE2131938A1 (fr) |
FR (1) | FR2100839B1 (fr) |
GB (1) | GB1351501A (fr) |
HU (1) | HU163640B (fr) |
NL (1) | NL7108858A (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3922261A (en) * | 1972-06-21 | 1975-11-25 | Merck Patent Gmbh | Adenosine derivative |
US5066655A (en) * | 1987-04-24 | 1991-11-19 | Whitby Research, Inc. | N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |
US5565566A (en) * | 1987-04-24 | 1996-10-15 | Discovery Therapeutics, Inc. | N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists |
US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
US5155098A (en) * | 1989-06-09 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them |
WO1992005177A1 (fr) * | 1990-09-25 | 1992-04-02 | Rhone-Poulenc Rorer International (Holdings) Inc. | Composes possedant des proprietes anti-hypertensives et anti-ischemiques |
US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
DK62592D0 (fr) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
JP3933870B2 (ja) | 1998-06-23 | 2007-06-20 | グラクソ グループ リミテッド | 2−(プリン−9−イル)−テトラヒドロフラン−3,4−ジオール誘導体 |
US7205404B1 (en) * | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
AU7361400A (en) * | 1999-09-08 | 2001-04-10 | Metabasis Therapeutics, Inc. | Prodrugs for liver specific drug delivery |
PE20060272A1 (es) | 2004-05-24 | 2006-05-22 | Glaxo Group Ltd | (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
CN114404427A (zh) | 2014-02-13 | 2022-04-29 | 配体药物公司 | 前药化合物及其用途 |
US9994600B2 (en) | 2014-07-02 | 2018-06-12 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
EP3737676B1 (fr) | 2018-01-09 | 2024-03-06 | Ligand Pharmaceuticals, Inc. | Composés acétal et leurs utilisations thérapeutiques |
-
1971
- 1971-06-23 US US00156138A patent/US3796700A/en not_active Expired - Lifetime
- 1971-06-23 BE BE768925A patent/BE768925A/fr unknown
- 1971-06-25 NL NL7108858A patent/NL7108858A/xx unknown
- 1971-06-26 DE DE19712131938 patent/DE2131938A1/de active Pending
- 1971-06-28 GB GB3012371A patent/GB1351501A/en not_active Expired
- 1971-06-29 FR FR7123583A patent/FR2100839B1/fr not_active Expired
- 1971-06-29 HU HUTA1126A patent/HU163640B/hu unknown
- 1971-06-30 CA CA117,084A patent/CA954856A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB1351501A (en) | 1974-05-01 |
FR2100839B1 (fr) | 1974-09-06 |
HU163640B (fr) | 1973-09-27 |
BE768925A (fr) | 1971-11-03 |
CA954856A (en) | 1974-09-17 |
US3796700A (en) | 1974-03-12 |
DE2131938A1 (de) | 1972-01-05 |
FR2100839A1 (fr) | 1972-03-24 |